Navigation Links
Success of Hepatitis C Drugs May Depend on Gene Variant
Date:6/13/2010

Researchers hope to identify patients for whom treatment will be ineffective

SATURDAY, June 12 (HealthDay News) -- A genetic variant associated with poor response to treatment for hepatitis C infection has been identified by scientists.

The researchers analyzed the DNA of 1,362 hepatitis C patients and pinpointed the variant in those who failed to respond to treatment. The variant occurs in a gene called IL28B, which encodes for the antiviral cytokine (cell-signaling) interferon lambda.

The study was to be presented Saturday at the annual conference of the European Society of Human Genetics.

Current treatment for hepatitis C includes a combination of an interferon and the antiviral medication ribavirin. Side effects are common and can be so serious that some people have to take time off work.

Identifying hepatitis C patients with this genetic variant could spare them from suffering side effects from a treatment that will provide them with little benefit, said the scientists at the University of Lausanne in Switzerland in a news release from the European Society of Human Genetics.

The research may also help in the development of new treatments, they said.

More information

The American Academy of Family Physicians has more about hepatitis C.



-- Robert Preidt



SOURCE: European Society of Human Genetics, news release, June 12, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Connecture, Inc. Launches New Technology Package to Increase Health Insurance Carriers' Success in the Online Individual Market
2. SIS Rules-Based Charging Solution Successfully Peer Reviewed by HFMA for Third Consecutive Year
3. Parabit Systems Successfully Installs Infant Protection Systems at Major Long Island Hospitals
4. Injections May Boost Knee Surgery Success
5. From Conflict to Consensus: Interaction Associates Outlines How Leaders Can Achieve Successful Alignment and Implementation
6. Pathological Gambling May Be Successfully Treated With Medications for Substance Addiction
7. First successful use of expanded umbilical-cord blood units to treat leukemia
8. Race, Weight May Influence Success of Prostate Surgery
9. Allegheny Medical Achieves Remarkable Success with Their Fibromyalgia Flow Care Plan
10. AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign
11. Local Businesses Team with Success 4 Kids & Families to Provide Holiday Gifts and Meals for Needy Families
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Success of Hepatitis C Drugs May Depend on Gene Variant
(Date:1/19/2017)... ... 2017 , ... Wells Pharmacy Network announced the completion of ... pharmacy located in Ocala, Florida. , Meeting the Needs of a Growing ... States for high-quality human anti-aging and wellness compounded medications, Wells Pharmacy ...
(Date:1/19/2017)... ... January 19, 2017 , ... Remote Medical ... unveiled impressive transportable capabilities with their iMedHD2™ Portable Teleultrasound System. ... RMT technology that delivers HD, dynamic, streaming ultrasound images and video to one ...
(Date:1/19/2017)... IL (PRWEB) , ... January 19, 2017 , ... ... N.A., announced it recently provided a new $11,250,000 senior credit facility to Sunrise, ... new MB credit facility were used to facilitate a recapitalization of MedPro led ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... acoustic and privacy panel system. , The Tranquility privacy panel system was ... collaborative office environment. Tranquility panels help reduce noise and provide the visual privacy ...
(Date:1/19/2017)... ... , ... Tribble Insurance Agency, a family owned and operated firm offering asset ... event to honor Chad Phillip Dermyer, a local police trooper who was shot and ... his fellow officers were conducting routine stops of suspects when one of them, a ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Conference Call and Webcast to Follow Vanda Pharmaceuticals Inc. ... results for the fourth quarter of 2016 on Wednesday, February 15, ... ... PM ET on Wednesday, February 15, 2017, during which management will ... other corporate activities. To participate in the conference call, please dial ...
(Date:1/19/2017)... , Jan. 19, 2017 This report on ... and future scenario of the global market. Large number ... consumption. Severe chronic constipation is a major side effect ... laxatives. Hence, novel targeted therapy has been prescribed to ... launch of targeted medicines, and growing awareness about the ...
(Date:1/19/2017)... , Jan. 19, 2017  Stealth BioTherapeutics Inc. ... to treat mitochondrial dysfunction, today announced new additions to ... M.D., as Chief Medical Officer, and Daniel Geffken ... announced that Jim Carr , Pharm.D. has been ... "We are pleased to welcome Doug and Daniel to ...
Breaking Medicine Technology: